SlideShare a Scribd company logo
Electrolytes & Acid-Base Disturbance
Workshop
Mohammed Abdel Gawad MD, ESENeph
Lecturer of Nephrology, School of Medicine, NewGiza University
Founder of NephroTube.com
ISN Education SoMe Team Member
Co-chair of AFRAN Web/Media Committee
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
History
• An 18-year-old man presents with the complaint of nocturia and polyuria. His 24-hour
urine volume is 4.2 L. He has no other medical history.
Physical
examination
• BP of 115/70 mmHg
• heart of 72 beats per minute
• He is afebrile
• The rest of the examination is unremarkable
Blood tests
• sodium, 130 mEq/L
• potassium, 3.9 mEq/L
• chloride, 95 mEq/L
• bicarbonate, 26 mEq/L
• BUN, 10 mg/dl
• creatinine, 0.8 mg/dl
Urine tests
• sodium, 11 mEq/L
• potassium, 20 mEq/L
• volume, 4.2 L/d
• osmolality, 90 mOsm/L
What is the most likely cause of his hyponatremia?
A. SIADH
B. Occult diuretic use
C. Hypothyroidism
D. Primary polydipsia
Case #1 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
5
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
History
• A 75-year-old man with recently diagnosed pancreatic cancer and hypertension (on
lisinopril and chlorthalidone).
Physical
examination
• He is intermittently agitated and disoriented with infrequent seizures
• The BP is 140/85 mmHg, and the pulse rate is 85/min
• The remainder of examination is unremarkable
Blood tests
• sodium of 115 mEq/L
• potassium of 3.9 mEq/L
• BUN of 6 mg/dl
• creatinine of 0.8 mg/dl
• glucose of 106 mg/dl
• calcium of 9.0 mg/dl
• serum osmolality of 236mOsm/kg
Urine tests
• The urine osmolality is 380 mOsm/kg
• The urine sodium is 40 mEq/L, and the urine potassium is 30 mEq/L
In addition to fluid restriction and discontinuing chlorthalidone, what is the MOST next step in management?
A. No additional interventions
B. 3% saline to increase SNa+ 4–6 mEq/L
C. Tolvaptan
D. Furosemide plus intravenous isotonic saline with potassium chloride
Case #2 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2017-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
Repeat serum Na
Exclude Drugs
4
5
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
Maximum:
Repeat twice
Maximum:
5 mmol/l
increase
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
First-hour management:
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia - Management – Severe Symptoms
General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
If the symptoms still have not improved, it is unlikely that the
symptoms are due to the hyponatremia and alternative
explanations should be sought
Handbook of Critical Care Nephrology. Chapter 19. 2021
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
Case #3 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 38-year-old woman entered the emergency department with weakness, frequent
urination (UOP; 8L/d), and increased thirst.
Physical
examination
• Heart rate of 80 beats per minute
• BP of 120/80 mmHg supine and 115/75 mmHg upright
• The rest of the examination was noncontributory.
Blood tests
• sodium, 156 mEq/L
• potassium, 3.7 mEq/L
• chloride, 123.0 mEq/L
• bicarbonate, 24.0 mEq/L
• creatinine, 0.9 mg/dl
• BUN, 22.0 mg/ dl
• glucose, 130 mg/dl
• calcium, 9.1 mg/dl.
Urine tests • Urine osmolality was 88 mmol/kg
Which ONE of the following would MOST likely reveal the cause of her electrolyte disorder?
A. Fluid deprivation test
B. Plasma cortisol assay
C. Serum thyroid-stimulating hormone assay
D. Estimation of urinary osmoles
AJKD. VOLUME 72, ISSUE 5, PA17-A19, NOVEMBER 01, 2018
Polyuria –
Approach 1
urine osmolality ×
urine volume >900
mosmol/day
Am J Kidney Dis. 67(3):507-511, 2016.
Polyuria –
Approach 2
Am J Kidney Dis. 2016 Mar;67(3):507-11
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
Case #4 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 38-year-old man presents with a recent history of hypertension.
• He is referred to you for further evaluation. He is currently being treated with a CCB.
Physical
examination
• BP of 165/90 mmHg supine and standing
• Heart rate of 62 beats per minute
• The rest of the examination is unremarkable
Blood tests
• sodium, 138 mEq/L
• potassium, 2.9 mEq/L
• chloride, 100 mEq/L
• metabolic alkalosis
• BUN, 16 mg/dl
• creatinine, 0.9mg/dl.
Urine tests • Urine K/Cr ratio, 35
• Urine chloride, 35 mmol/L
At this point, which ONE of the following should be done?
A. Plasma aldosterone to renin ratio
B. Abdominal CT scan
C. 24-hour urinary aldosterone level
D. Thyroid function test
Acta Med Indones. Jan-Mar 2007;39(1):56-64.
Acta Med Indones. Jan-Mar 2007;39(1):56-64.
Acta Med Indones. Jan-Mar 2007;39(1):56-64.
Glucocorticoid remediable aldosteronism
Acta Med Indones. Jan-Mar 2007;39(1):56-64.
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
Case #5 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2014-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 56-year-old man was diagnosed with colon cancer 3 years ago and had successful
surgery and postoperative chemotherapy.
• He denies weight loss, abdominal pain, jaundice, confusion, constipation, or polyuria.
• The patient drinks three to four “health tonics” rich in calcium and several servings of
milk and calcium-fortified orange juice daily.
CT scan
• He now has a possible metastatic lesion of the liver that was seen on a recent
abdominal computed tomography (CT) scan.
Blood tests
• serum calcium, 12.5 mg/dl
• undetectable serum (PTH)
• serum PTHrP, normal
• serum 25(OH)D 288 ng/ml (N, 25–80 ng/ml),
• serum 1,25(OH)2D 72 pg/ml (N, 25–65 pg/ml)
Which ONE of the following is the MOST likely cause of this patient’s hypercalcemia?
A. Recurrent colon cancer-producing PTHrP
B. Bone metastases
C. Vitamin D intoxication
D. Sarcoidosis
E. Excess calcium intake
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
Case #6 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2012-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 70-year-old man was admitted to the hospital after he had lost consciousness.
• He had a history of peptic ulcer disease, hypertension, and hyperlipidemia.
• He was treated with lisinopril, atorvastatin, and omeprazole.
ECG • Rapid supraventricular tachycardia
Blood tests
• hypomagnesemia
• hypocalcemia
• hypokalemia
Beside management of his electrolyte disturbances, which ONE of the following should be the next step?
A. Measure PTH.
B. Measure calcitonin.
C. Discontinue omeprazole.
D. Discontinue atorvastatin.
E. Measure the renin/aldosterone ratio.
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
History
• A 70-year-old man with recently diagnosed monoclonal Ig deposition disease is evaluated
for hyperphosphatemia.
• He began therapy with bortezomib, lenalidomide, and dexamethasone 2 days ago.
• His urine output has been normal, and he complains of fatigue.
Blood tests
• sodium of 136 mEq/L
• potassium of 4.2 mEq/L
• BUN of 25 mg/dl, creatinine of 1.3 mg/dl
• calcium of 9.1 mg/dl
• phosphorus of 6.6 mg/dl
• Normal LDH
• uric acid of 4.2 mg/dl
• leukocyte count of 4700/ml
• hemoglobin 9.6 of g/dl
• The serum IgG is 14,400 mg/dl
(reference range=600–1700 mg/dl)
• Serum free k-light chains, 1288 mg/dl
• serum free l-light chains are 2.16 mg/dl.
Which ONE of the following is the MOST likely cause of this man's hyperphosphatemia?
A. Tumor lysis syndrome
B. Decreased GFR
C. Elevated IgGk monoclonal protein
D. Rhabdomyolysis
Case #7 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2016-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
Case #8 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 25-year-old woman with recurrent kidney stones.
• She reports intermittent episodes of constipation
alternating with diarrhea.
Physical
examination
• BP is 106/70 mmHg
• The remainder of the examination is normal
Blood tests
• Na 137 mEq/L
• K 3.1 mEq/L
• Cl 114 mEq/L
• HCO3 11 mEq/L
• BUN 13
mg/dl
• creatinine
1.2 mg/dl
• Venous blood gas
metabolic acidosis
Urine tests • Na 60 mEq/L
• K 50 mEq/L
• Cl 42 mEq/L. • pH 6.5
• specific gravity 1.014
Which ONE of the following is the MOST likely diagnosis?
A. Proximal RTA
B. Barium sulfide toxicity
C. Type I distal RTA
D. Toluene toxicity
Metabolic Acidosis
Calculate Anion Gap
AG
HCO3-
Cl-
Na + K
AG
HCO3-
Cl-
Na + K
Wide anion gap
Normo-cholremic
Acidosis
Na + K
AG
HCO3-
Cl-
Cl-
Normal anion gap
Hyper-cholremic
Acidosis
Corrected Anion Gap: anion gap is decreased by 2.5
mmol/l for each 1 g/dl decrease in the serum albumin
concentration below normal.
AG = (Na + K) – (Cl + HCO3) = 16 ± 4 mmol/l
AG = (Na) – (Cl + HCO3) = 12 ± 4 mmol/l
33
4- uretrosigmoid-
ostomy
Non-Anion Gap Causes
Hypercholeremic
Approved Metabolic Acidosis
Calculate Anion Gap
• a- if high anion gap → calculate delta gap
• b- if normal anion gap → calculate urinary AG
2- b- if normal anion gap → calculate urinary AG
4- uretrosigmoid-ostomy
NH4Cl
2- b- if normal anion gap → calculate urinary AG
4- uretrosigmoid-ostomy
NH4Cl
urine AG = u[Na + K] – u[Cl]
If –ve: so the loss is non renal
If zero or +ve: so the loss is renal
Thank You
drgawad@gmail.com
twitter: @Gawad_Nephro
Facebook: Doctor.Gawad
www.NephroTube.com

More Related Content

What's hot

Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
Christos Argyropoulos
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
NephroTube - Dr.Gawad
 
Hypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. GawadHypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
Harsh shaH
 
Compartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
Compartmental Syndrome (What Nephrologists should know?) - Dr. GawadCompartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
Compartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. GawadCKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. Gawad
NephroTube - Dr.Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
NephroTube - Dr.Gawad
 
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. GawadDrug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
NephroTube - Dr.Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Dkd master class
Dkd master class Dkd master class
Dkd master class
FarragBahbah
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
NephroTube - Dr.Gawad
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
NephroTube - Dr.Gawad
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
NephroTube - Dr.Gawad
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
NephroTube - Dr.Gawad
 
Hepatorenal syndrome recent advances
Hepatorenal syndrome recent advancesHepatorenal syndrome recent advances
Hepatorenal syndrome recent advances
Kushal Dp
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 

What's hot (20)

Hyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. GawadHyperkalemia (Practical Approach) - Dr. Gawad
Hyperkalemia (Practical Approach) - Dr. Gawad
 
KDIGO CKD 2012
KDIGO CKD 2012KDIGO CKD 2012
KDIGO CKD 2012
 
Diabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 UpdateDiabetic Kidney Disease 2022 Update
Diabetic Kidney Disease 2022 Update
 
CRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. GawadCRRT in ICU - AKI - Dr. Gawad
CRRT in ICU - AKI - Dr. Gawad
 
Hypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. GawadHypernatremia (Practical Approach) - Dr. Gawad
Hypernatremia (Practical Approach) - Dr. Gawad
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
 
Compartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
Compartmental Syndrome (What Nephrologists should know?) - Dr. GawadCompartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
Compartmental Syndrome (What Nephrologists should know?) - Dr. Gawad
 
CKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. GawadCKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. Gawad
 
Contrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. GawadContrast and the kidney - Dr. Gawad
Contrast and the kidney - Dr. Gawad
 
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. GawadDrug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
Drug Dosing and Prescription in CKD & ESRD (Updates - Highlights) - Dr. Gawad
 
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadIgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
IgA Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
 
Dkd master class
Dkd master class Dkd master class
Dkd master class
 
Hypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. GawadHypercalcemia (Practical Approach) - Dr. Gawad
Hypercalcemia (Practical Approach) - Dr. Gawad
 
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. GawadCKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
CKD Mineral Bone Disorder (CKD-MBD) - Dr. Gawad
 
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadRenal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
Renal Replacement therapy (Dialytic Management) in AKI - Dr.Gawad
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
 
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...
 
Hepatorenal syndrome recent advances
Hepatorenal syndrome recent advancesHepatorenal syndrome recent advances
Hepatorenal syndrome recent advances
 
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. GawadANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
ANCA vasculitis (KDIGO 2021 Guidelines) - Dr. Gawad
 

Similar to Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad

Acid-Base disorders and ICU deaths morbidity
Acid-Base disorders and ICU deaths morbidityAcid-Base disorders and ICU deaths morbidity
Acid-Base disorders and ICU deaths morbidity
sanjay07vp
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
DrRohitGupta10
 
Med scape April2015
Med scape April2015Med scape April2015
Med scape April2015
Chonpiti Siriwan
 
Gastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver FailureGastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver Failure
ApolloGleaneagls
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
NephroTube - Dr.Gawad
 
Approach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptxApproach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptx
MariaFatima374066
 
Farrag case presention
Farrag case presentionFarrag case presention
Farrag case presention
FarragBahbah
 
ascites-140326120942-phpapp01.pptx
ascites-140326120942-phpapp01.pptxascites-140326120942-phpapp01.pptx
ascites-140326120942-phpapp01.pptx
KhooChunYik
 
Cva case stroke
Cva case strokeCva case stroke
Cva case stroke
Umme Habeeba A Pathan
 
Clinical pathology spots for final MBBS
Clinical pathology spots for final MBBSClinical pathology spots for final MBBS
Clinical pathology spots for final MBBS
Yapa
 
HIF CASE
HIF CASEHIF CASE
HIF CASE
kotte swaran
 
Medical Management of Anaemia & Case Studies (1).pdf
Medical Management of Anaemia & Case Studies (1).pdfMedical Management of Anaemia & Case Studies (1).pdf
Medical Management of Anaemia & Case Studies (1).pdf
samrawitmekonnen16
 
Hemochromatosis presentation
Hemochromatosis presentationHemochromatosis presentation
Hyponatremia gulidelines
Hyponatremia  gulidelinesHyponatremia  gulidelines
Hyponatremia gulidelinesViquas Saim
 
How to approach hypercalcaemia?
How to approach hypercalcaemia?How to approach hypercalcaemia?
How to approach hypercalcaemia?
Adeel Rafi Ahmed
 
management of Fluid & electrolytes disturbances.pptx
management of Fluid & electrolytes disturbances.pptxmanagement of Fluid & electrolytes disturbances.pptx
management of Fluid & electrolytes disturbances.pptx
hmgamh8
 
Hyponatremia
Hyponatremia Hyponatremia
Hyponatremia
Vandana G.Hari
 
Case studies
Case studiesCase studies
Case studies
Salwa Ibrahim
 

Similar to Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad (20)

Acid-Base disorders and ICU deaths morbidity
Acid-Base disorders and ICU deaths morbidityAcid-Base disorders and ICU deaths morbidity
Acid-Base disorders and ICU deaths morbidity
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Med scape April2015
Med scape April2015Med scape April2015
Med scape April2015
 
Gastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver FailureGastrocon 2016 - Acute Liver Failure
Gastrocon 2016 - Acute Liver Failure
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Chakraborty APPI Mumbai 140615
Chakraborty APPI Mumbai 140615Chakraborty APPI Mumbai 140615
Chakraborty APPI Mumbai 140615
 
Approach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptxApproach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptx
 
Farrag case presention
Farrag case presentionFarrag case presention
Farrag case presention
 
ascites-140326120942-phpapp01.pptx
ascites-140326120942-phpapp01.pptxascites-140326120942-phpapp01.pptx
ascites-140326120942-phpapp01.pptx
 
Dialysis
DialysisDialysis
Dialysis
 
Cva case stroke
Cva case strokeCva case stroke
Cva case stroke
 
Clinical pathology spots for final MBBS
Clinical pathology spots for final MBBSClinical pathology spots for final MBBS
Clinical pathology spots for final MBBS
 
HIF CASE
HIF CASEHIF CASE
HIF CASE
 
Medical Management of Anaemia & Case Studies (1).pdf
Medical Management of Anaemia & Case Studies (1).pdfMedical Management of Anaemia & Case Studies (1).pdf
Medical Management of Anaemia & Case Studies (1).pdf
 
Hemochromatosis presentation
Hemochromatosis presentationHemochromatosis presentation
Hemochromatosis presentation
 
Hyponatremia gulidelines
Hyponatremia  gulidelinesHyponatremia  gulidelines
Hyponatremia gulidelines
 
How to approach hypercalcaemia?
How to approach hypercalcaemia?How to approach hypercalcaemia?
How to approach hypercalcaemia?
 
management of Fluid & electrolytes disturbances.pptx
management of Fluid & electrolytes disturbances.pptxmanagement of Fluid & electrolytes disturbances.pptx
management of Fluid & electrolytes disturbances.pptx
 
Hyponatremia
Hyponatremia Hyponatremia
Hyponatremia
 
Case studies
Case studiesCase studies
Case studies
 

More from NephroTube - Dr.Gawad

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
NephroTube - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
NephroTube - Dr.Gawad
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
NephroTube - Dr.Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
NephroTube - Dr.Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
NephroTube - Dr.Gawad
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
NephroTube - Dr.Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
NephroTube - Dr.Gawad
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
NephroTube - Dr.Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
NephroTube - Dr.Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
NephroTube - Dr.Gawad
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
NephroTube - Dr.Gawad
 

More from NephroTube - Dr.Gawad (20)

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
Vitamin D in Chronic Kidney Disease Which type, Which dose, Which patient? - ...
 
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. GawadUrinary Tract Infection (Clinical Tips) - Dr. Gawad
Urinary Tract Infection (Clinical Tips) - Dr. Gawad
 
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. GawadObesity and the Kidney (Link and Evidence) - Dr. Gawad
Obesity and the Kidney (Link and Evidence) - Dr. Gawad
 
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadThrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. Gawad
 
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. GawadAsymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
Asymptomatic Hyperuricemia with CKD (To Treat or Not To Treat) - Dr. Gawad
 
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. GawadLupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Lupus Nephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. GawadMembranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
Membranous Nephropathy (KDIGO 2021 Guidelines) - Dr. Gawad
 
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. GawadInfection-related Glomerulonephritis  (KDIGO 2021 Guidelines) - Dr. Gawad
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. Gawad
 
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
Ig & complement-mediated glomerular dis with MPGN pattern (KDIGO 2021) - Dr.G...
 
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. GawadFocal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
Focal Segmental Glomerulosclerosis - FSGS (KDIGO 2021 Guidelines) - Dr. Gawad
 
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)Adult Minimal Change Disease (KDIGO 2021 Guidelines)
Adult Minimal Change Disease (KDIGO 2021 Guidelines)
 
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadInsights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. Gawad
 
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadDiabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. Gawad
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
 
Hypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. GawadHypocalcemia (Practical Approach) - Dr. Gawad
Hypocalcemia (Practical Approach) - Dr. Gawad
 
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
Catheter Related Blood Stream Infection (CRBSI) - (Diagnosis & Management Ste...
 

Recently uploaded

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 

Recently uploaded (20)

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 

Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad

  • 1. Electrolytes & Acid-Base Disturbance Workshop Mohammed Abdel Gawad MD, ESENeph Lecturer of Nephrology, School of Medicine, NewGiza University Founder of NephroTube.com ISN Education SoMe Team Member Co-chair of AFRAN Web/Media Committee
  • 2. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 3. History • An 18-year-old man presents with the complaint of nocturia and polyuria. His 24-hour urine volume is 4.2 L. He has no other medical history. Physical examination • BP of 115/70 mmHg • heart of 72 beats per minute • He is afebrile • The rest of the examination is unremarkable Blood tests • sodium, 130 mEq/L • potassium, 3.9 mEq/L • chloride, 95 mEq/L • bicarbonate, 26 mEq/L • BUN, 10 mg/dl • creatinine, 0.8 mg/dl Urine tests • sodium, 11 mEq/L • potassium, 20 mEq/L • volume, 4.2 L/d • osmolality, 90 mOsm/L What is the most likely cause of his hyponatremia? A. SIADH B. Occult diuretic use C. Hypothyroidism D. Primary polydipsia Case #1 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
  • 4. 5 Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 5. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 6. History • A 75-year-old man with recently diagnosed pancreatic cancer and hypertension (on lisinopril and chlorthalidone). Physical examination • He is intermittently agitated and disoriented with infrequent seizures • The BP is 140/85 mmHg, and the pulse rate is 85/min • The remainder of examination is unremarkable Blood tests • sodium of 115 mEq/L • potassium of 3.9 mEq/L • BUN of 6 mg/dl • creatinine of 0.8 mg/dl • glucose of 106 mg/dl • calcium of 9.0 mg/dl • serum osmolality of 236mOsm/kg Urine tests • The urine osmolality is 380 mOsm/kg • The urine sodium is 40 mEq/L, and the urine potassium is 30 mEq/L In addition to fluid restriction and discontinuing chlorthalidone, what is the MOST next step in management? A. No additional interventions B. 3% saline to increase SNa+ 4–6 mEq/L C. Tolvaptan D. Furosemide plus intravenous isotonic saline with potassium chloride Case #2 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2017-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
  • 7. Repeat serum Na Exclude Drugs 4 5 Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 8. IV infusion of 150 ml 3% hypertonic (2 ml/kg) in case of obviously deviant body composition 20 min check serum Na Maximum: Repeat twice Maximum: 5 mmol/l increase A. Improvement of symptoms → Stop 3% infusion B. No improvement of symptoms → continue infusion targeting general rules of raising serum Na keep the i.v. line open by infusing the smallest feasible volume of 0.9% saline until cause- specific treatment is started First-hour management: Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39 Hyponatremia - Management – Severe Symptoms
  • 9. General rules – 0.9% or 3% NaCl infusion Maximum correction limit (i.e. Stop infusion when) 10 mmol/l in the first 24 h 8 mmol/l during every 24 h thereafter 130 mmol/l is reached or serum sodium concentration increases 10 mmol/l in total symptoms improved If the symptoms still have not improved, it is unlikely that the symptoms are due to the hyponatremia and alternative explanations should be sought Handbook of Critical Care Nephrology. Chapter 19. 2021 Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
  • 10. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 11. Case #3 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad History • A 38-year-old woman entered the emergency department with weakness, frequent urination (UOP; 8L/d), and increased thirst. Physical examination • Heart rate of 80 beats per minute • BP of 120/80 mmHg supine and 115/75 mmHg upright • The rest of the examination was noncontributory. Blood tests • sodium, 156 mEq/L • potassium, 3.7 mEq/L • chloride, 123.0 mEq/L • bicarbonate, 24.0 mEq/L • creatinine, 0.9 mg/dl • BUN, 22.0 mg/ dl • glucose, 130 mg/dl • calcium, 9.1 mg/dl. Urine tests • Urine osmolality was 88 mmol/kg Which ONE of the following would MOST likely reveal the cause of her electrolyte disorder? A. Fluid deprivation test B. Plasma cortisol assay C. Serum thyroid-stimulating hormone assay D. Estimation of urinary osmoles
  • 12. AJKD. VOLUME 72, ISSUE 5, PA17-A19, NOVEMBER 01, 2018 Polyuria – Approach 1
  • 13. urine osmolality × urine volume >900 mosmol/day Am J Kidney Dis. 67(3):507-511, 2016. Polyuria – Approach 2
  • 14. Am J Kidney Dis. 2016 Mar;67(3):507-11
  • 15. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 16. Case #4 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad History • A 38-year-old man presents with a recent history of hypertension. • He is referred to you for further evaluation. He is currently being treated with a CCB. Physical examination • BP of 165/90 mmHg supine and standing • Heart rate of 62 beats per minute • The rest of the examination is unremarkable Blood tests • sodium, 138 mEq/L • potassium, 2.9 mEq/L • chloride, 100 mEq/L • metabolic alkalosis • BUN, 16 mg/dl • creatinine, 0.9mg/dl. Urine tests • Urine K/Cr ratio, 35 • Urine chloride, 35 mmol/L At this point, which ONE of the following should be done? A. Plasma aldosterone to renin ratio B. Abdominal CT scan C. 24-hour urinary aldosterone level D. Thyroid function test
  • 17. Acta Med Indones. Jan-Mar 2007;39(1):56-64.
  • 18. Acta Med Indones. Jan-Mar 2007;39(1):56-64.
  • 19. Acta Med Indones. Jan-Mar 2007;39(1):56-64.
  • 20. Glucocorticoid remediable aldosteronism Acta Med Indones. Jan-Mar 2007;39(1):56-64.
  • 21. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 22. Case #5 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2014-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad History • A 56-year-old man was diagnosed with colon cancer 3 years ago and had successful surgery and postoperative chemotherapy. • He denies weight loss, abdominal pain, jaundice, confusion, constipation, or polyuria. • The patient drinks three to four “health tonics” rich in calcium and several servings of milk and calcium-fortified orange juice daily. CT scan • He now has a possible metastatic lesion of the liver that was seen on a recent abdominal computed tomography (CT) scan. Blood tests • serum calcium, 12.5 mg/dl • undetectable serum (PTH) • serum PTHrP, normal • serum 25(OH)D 288 ng/ml (N, 25–80 ng/ml), • serum 1,25(OH)2D 72 pg/ml (N, 25–65 pg/ml) Which ONE of the following is the MOST likely cause of this patient’s hypercalcemia? A. Recurrent colon cancer-producing PTHrP B. Bone metastases C. Vitamin D intoxication D. Sarcoidosis E. Excess calcium intake
  • 23.
  • 24. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 25. Case #6 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2012-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad History • A 70-year-old man was admitted to the hospital after he had lost consciousness. • He had a history of peptic ulcer disease, hypertension, and hyperlipidemia. • He was treated with lisinopril, atorvastatin, and omeprazole. ECG • Rapid supraventricular tachycardia Blood tests • hypomagnesemia • hypocalcemia • hypokalemia Beside management of his electrolyte disturbances, which ONE of the following should be the next step? A. Measure PTH. B. Measure calcitonin. C. Discontinue omeprazole. D. Discontinue atorvastatin. E. Measure the renin/aldosterone ratio.
  • 26.
  • 27. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 28. History • A 70-year-old man with recently diagnosed monoclonal Ig deposition disease is evaluated for hyperphosphatemia. • He began therapy with bortezomib, lenalidomide, and dexamethasone 2 days ago. • His urine output has been normal, and he complains of fatigue. Blood tests • sodium of 136 mEq/L • potassium of 4.2 mEq/L • BUN of 25 mg/dl, creatinine of 1.3 mg/dl • calcium of 9.1 mg/dl • phosphorus of 6.6 mg/dl • Normal LDH • uric acid of 4.2 mg/dl • leukocyte count of 4700/ml • hemoglobin 9.6 of g/dl • The serum IgG is 14,400 mg/dl (reference range=600–1700 mg/dl) • Serum free k-light chains, 1288 mg/dl • serum free l-light chains are 2.16 mg/dl. Which ONE of the following is the MOST likely cause of this man's hyperphosphatemia? A. Tumor lysis syndrome B. Decreased GFR C. Elevated IgGk monoclonal protein D. Rhabdomyolysis Case #7 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2016-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
  • 29.
  • 30. Cases • Case #1: Hyponatremia diagnosis • Case #2: Hyponatremia treatment • Case #3: Hypernatremia • Case #4: Potassium disorder • Case #5: Calcium disorder • Case #6: Magnesium disorder • Case #7: Phosphorus disorder • Case #8: Acid-Base disorder
  • 31. Case #8 Electrolytes, Acid-Base Disturbance Workshop Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad History • A 25-year-old woman with recurrent kidney stones. • She reports intermittent episodes of constipation alternating with diarrhea. Physical examination • BP is 106/70 mmHg • The remainder of the examination is normal Blood tests • Na 137 mEq/L • K 3.1 mEq/L • Cl 114 mEq/L • HCO3 11 mEq/L • BUN 13 mg/dl • creatinine 1.2 mg/dl • Venous blood gas metabolic acidosis Urine tests • Na 60 mEq/L • K 50 mEq/L • Cl 42 mEq/L. • pH 6.5 • specific gravity 1.014 Which ONE of the following is the MOST likely diagnosis? A. Proximal RTA B. Barium sulfide toxicity C. Type I distal RTA D. Toluene toxicity
  • 32. Metabolic Acidosis Calculate Anion Gap AG HCO3- Cl- Na + K AG HCO3- Cl- Na + K Wide anion gap Normo-cholremic Acidosis Na + K AG HCO3- Cl- Cl- Normal anion gap Hyper-cholremic Acidosis Corrected Anion Gap: anion gap is decreased by 2.5 mmol/l for each 1 g/dl decrease in the serum albumin concentration below normal. AG = (Na + K) – (Cl + HCO3) = 16 ± 4 mmol/l AG = (Na) – (Cl + HCO3) = 12 ± 4 mmol/l
  • 34. Approved Metabolic Acidosis Calculate Anion Gap • a- if high anion gap → calculate delta gap • b- if normal anion gap → calculate urinary AG
  • 35. 2- b- if normal anion gap → calculate urinary AG 4- uretrosigmoid-ostomy NH4Cl
  • 36. 2- b- if normal anion gap → calculate urinary AG 4- uretrosigmoid-ostomy NH4Cl urine AG = u[Na + K] – u[Cl] If –ve: so the loss is non renal If zero or +ve: so the loss is renal
  • 37.